SYK and colitis: In addition, the use of Syk inhibitors, Cerdulatinib, Fostamatinib, and TOP1210, can ameliorate severity of experimental colitis by inhibiting release of proinflammatory cytokines and reducing mucosal damage.10, 15, 16